DCF — BAPTIST HEALTH MED CTR ARKADELPHIA
Enterprise Value: $-18.8M
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
$-18.8M
Enterprise Value
$-6.6M
PV of Cash Flows
$-12.2M
PV of Terminal Value
$-19.7M
Terminal Value
10.0%
WACC
2.5%
Terminal Growth
Cash Flow Projections
PROJ| Year | Revenue | EBITDA | Margin | FCF | PV(FCF) |
|---|---|---|---|---|---|
| Year 1 | $31.0M | $-0.8M | -3.0% | $-2.1M | $-1.9M |
| Year 2 | $32.0M | $-0.5M | -2.0% | $-1.9M | $-1.6M |
| Year 3 | $32.9M | $-0.2M | -1.0% | $-1.6M | $-1.2M |
| Year 4 | $33.9M | $-0.0M | -0.0% | $-1.5M | $-1.0M |
| Year 5 | $34.9M | $0.0M | 0.0% | $-1.4M | $-0.9M |
Interpretation
INTAt a WACC of 10.0% and terminal growth of 2.5%, enterprise value is $-18.8M. Terminal value accounts for 0% of total EV — consider sensitivity to terminal assumptions.
Next steps: Check the LBO model to see equity returns at this entry price, or the EBITDA bridge to model value creation levers.
Assumptions
ASSMrevenue base$30.1M
revenue growth rates[0.03, 0.03, 0.03, 0.03, 0.03]
ebitda margin base-0.03144752061450008
ebitda margin improvement bps[50, 100, 100, 50, 25]
capex pct revenue0.04
nwc pct revenue0.08
tax rate0.25
projection years5